The company reported a 22 percent increase in gross profit and 25 percent improvement in earnings as a percentage of net revenue compared to the second quarter of 2018.
“Our focus [in the] second quarter was to expand product development in our spine and orthopedic offerings, for which we expect to see continued growth and acceptance through the last half of 2019,” said CEO Christopher Reeg.
The company reported $2.8 million in gross profit and $5 million in net revenue.
More articles on orthopedic devices:
Who had the best Q2? How 12 spine, orthopedic companies performed
Orthofix aims to have 150 surgeons trained in M6-C cervical disc this year
Spine device company appoints new sales executive
